1,997
Views
26
CrossRef citations to date
0
Altmetric
Editorial

Prognostic markers in esophageal cancer: from basic research to clinical use

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Wanli Yang, Yu Han, Xinhui Zhao, Lili Duan, Wei Zhou, Xiaoqian Wang, Gaokai Shi, Yinggang Che, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong & Daiming Fan. (2019) Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 19:2, pages 109-119.
Read now
Wanli Yang, Jiaojiao Ma, Wei Zhou, Xin Zhou, Bo Cao, Hongwei Zhang, Qingchuan Zhao, Daiming Fan & Liu Hong. (2017) Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer. Expert Review of Gastroenterology & Hepatology 11:12, pages 1151-1163.
Read now
Wanli Yang, Jiaojiao Ma, Wei Zhou, Bo Cao, Xin Zhou, Zhiping Yang, Hongwei Zhang, Qingchuan Zhao, Daiming Fan & Liu Hong. (2017) Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opinion on Therapeutic Targets 21:11, pages 1063-1075.
Read now

Articles from other publishers (22)

Di Huang, Yujin Chu, Jiaoyan Qiu, Xiaoshuang Chen, Junhua Zhao, Yu Zhang, Shunjia Li, Yufeng Cheng, Han Shi, Lin Han & Jianbo Wang. (2023) A novel diagnostic signature of circulating tsRNAs and miRNAs in esophageal squamous cell carcinoma detected with a microfluidic platform. Analytica Chimica Acta 1272, pages 341520.
Crossref
Bing Wen, Dan-Xia Deng, Lian-Di Liao, Zhi-Da Zhang, Ya-Qi Zheng, Ke Dong, Li-Yan Xu & En-Min Li. (2023) Co-Expression of Chromatin Assembly Factor 1 Subunit A and Proliferating Cell Nuclear Antigen Is a Prognostic Biomarker of Esophageal Cancer. Biomedicines 11:4, pages 1184.
Crossref
Bin Song, Xiangchen Liu, Huiling Dong & Rupak Roy. (2022) miR-140-3P Induces Chemotherapy Resistance in Esophageal Carcinoma by Targeting the NFYA-MDR1 Axis. Applied Biochemistry and Biotechnology 195:2, pages 973-991.
Crossref
Nasir Nisar, Suhail Ahmad Mir, Ozaifa Kareem & Faheem Hyder Pottoo. 2023. Proteomics. Proteomics 77 120 .
Mario Dioguardi, Francesca Spirito, Diego Sovereto, Mario Alovisi, Riccardo Aiuto, Daniele Garcovich, Vito Crincoli, Luigi Laino, Angela Pia Cazzolla, Giorgia Apollonia Caloro, Michele Di Cosola, Andrea Ballini, Lorenzo Lo Muzio & Giuseppe Troiano. (2022) The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis. International Journal of Environmental Research and Public Health 19:9, pages 5334.
Crossref
Song-Tao Liu, Sen-Wang Zheng, A-Jiao Hou, Jia-Xu Zhang, Song Wang, Xue-Jiao Wang, Huan Yu & Liu Yang. (2022) A review: The phytochemistry, pharmacology, and pharmacokinetics of Curcumae Longae Rhizoma (Turmeric) . World Journal of Traditional Chinese Medicine 8:4, pages 463.
Crossref
Kholood Abid Janjua, Raheem Shahzad & Adeeb Shehzad. 2022. Cancer Biomarkers in Diagnosis and Therapeutics. Cancer Biomarkers in Diagnosis and Therapeutics 277 343 .
Mitsuro Kanda, Masahiko Koike, Dai Shimizu, Chie Tanaka, Norifumi Hattori, Masamichi Hayashi, Suguru Yamada, Kenji Omae & Yasuhiro Kodera. (2020) Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Annals of Surgical Oncology 27:9, pages 3195-3205.
Crossref
Mitsuro Kanda, Masahiko Koike & Yasuhiro Kodera. (2020) ASO Author Reflections: Characteristics Associated with Nodal and Distant Recurrence After Radical Esophagectomy for Squamous Cell Carcinoma of the Thoracic Esophagus. Annals of Surgical Oncology 27:9, pages 3206-3207.
Crossref
Changyu Shan, Wenqi Hui, Hongwei Li, Zheng Wang, Chunling Guo, Ruikun Peng, Jing Gu, Yingchun Chen & Qin Ouyang. (2020) Discovery of Novel Autophagy Inhibitors and Their Sensitization Abilities for Vincristine‐Resistant Esophageal Cancer Cell Line Eca109/VCR. ChemMedChem 15:11, pages 970-981.
Crossref
Mitsuro Kanda, Masahiko Koike, Dai Shimizu, Chie Tanaka, Daisuke Kobayashi, Norifumi Hattori, Masamichi Hayashi, Kenji Omae, Suguru Yamada, Goro Nakayama & Yasuhiro Kodera. (2019) Optimized Cutoff Value of Serum Squamous Cell Carcinoma Antigen Concentration Accurately Predicts Recurrence After Curative Resection of Squamous Cell Carcinoma of the Esophagus. Annals of Surgical Oncology 27:4, pages 1233-1240.
Crossref
Hong Zheng, Guosen Zhang, Lu Zhang, Qiang Wang, Huimin Li, Yali Han, Longxiang Xie, Zhongyi Yan, Yongqiang Li, Yang An, Huan Dong, Wan Zhu & Xiangqian Guo. (2020) Comprehensive Review of Web Servers and Bioinformatics Tools for Cancer Prognosis Analysis. Frontiers in Oncology 10.
Crossref
Mitsuro Kanda, Masahiko Koike, Chie Tanaka, Daisuke Kobayashi, Norifumi Hattori, Masamichi Hayashi, Suguru Yamada, Kenji Omae, Michitaka Fujiwara & Yasuhiro Kodera. (2019) Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus. Annals of Surgical Oncology 26:13, pages 4773-4781.
Crossref
Fangfang Li, Zhen Zhang, Peng Wang, Penghao Wen, Quanxiao Xu, Yunlong Wang, Ping Pan & Lei Ma. (2019) ALC1 knockdown enhances cisplatin cytotoxicity of esophageal squamous cell carcinoma cells by inhibition of glycolysis through PI3K/Akt pathway. Life Sciences 232, pages 116679.
Crossref
Yu Wu, Ye Yang & Yin-Sheng Xian. (2019) HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma. Chemico-Biological Interactions 308, pages 357-363.
Crossref
Gabriel Kigen, Naftali Busakhala, Zipporah Kamuren, Hillary Rono, Wilfred Kimalat & Evangeline Njiru. (2017) Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review. Infectious Agents and Cancer 12:1.
Crossref
Jianbo Li, Zhifan Zheng & Min Fang. (2017) Impact of pretreatment plasma D-dimer levels and its perioperative change on prognosis in operable esophageal squamous cell carcinoma. Oncotarget 8:45, pages 79537-79545.
Crossref
Takashi Miwa, Mitsuro Kanda, Masahiko Koike, Naoki Iwata, Haruyoshi Tanaka, Shinichi Umeda, Chie Tanaka, Daisuke Kobayashi, Masamichi Hayashi, Suguru Yamada, Tsutomu Fujii, Michitaka Fujiwara & Yasuhiro Kodera. (2017) Identification of NCCRP1 as an epigenetically regulated tumor suppressor and biomarker for malignant phenotypes of squamous cell carcinoma of the esophagus. Oncology Letters 14:4, pages 4822-4828.
Crossref
Fuqiang Dai, Longyong Mei, Shenglan Meng, Zheng Ma, Wei Guo, Jinghai Zhou & Jingge Zhang. (2017) The global expression profiling in esophageal squamous cell carcinoma. Genomics 109:3-4, pages 241-250.
Crossref
Jin Liu, Chuifang Wang, Xiangyan Liu, Yu Wang, Haibo Liu, Guohua Ren, Liangming Zhu, Zhigang Sun & Zhitao Chen. (2017) Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer. Oncology Letters 13:6, pages 4469-4474.
Crossref
Merve Mutlu, Umar Raza, Özge Saatci, Erol Eyüpoğlu, Emre Yurdusev & Özgür Şahin. (2016) miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Journal of Molecular Medicine 94:6, pages 629-644.
Crossref
Di Huang, Yujin Chu, Han Shi, Junhua Zhao, Yu Zhang, Shunjia Li, Lin Han, Jianbo Wang & Yufeng Cheng. (2022) A Novel Circulating Diagnostic Signature of tsRNAs and miRNAs in Esophageal Squamous Cell Carcinoma with a Multiplex and Rapid Microfluidic Detection Platform. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.